Advertisement

Related Videos

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement




Aug
11
Today In Oncology
Outreach to HCT Recipients, Primary Care Doctors May Reduce Skin Cancer Risk
American College of Surgeons Commission on Cancer Introduces Rural Cancer Program Accreditation
Phase III Trial Supports Intensified Total Neoadjuvant Therapy in High-Risk Rectal Cancer
Teclistamab Improves Progression-Free and Overall Survival in Previously Treated Multiple Myeloma
Oral Nicotinamide May Offer Cost-Effective Prevention of Keratinocyte Carcinoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo